<DOC>
	<DOC>NCT00202696</DOC>
	<brief_summary>To determine if nalmefene is safe and effective in smoking cessation.</brief_summary>
	<brief_title>Nalmefene Smoking Cessation Study</brief_title>
	<detailed_description>Single centered, randomized, placebo-controlled,double-blind, outpatient pilot study to evaluate the efficacy, safety and tolerability of 2 doses of nalmefene on smoking cessation.</detailed_description>
	<mesh_term>Nalmefene</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Smokers in good general health self reporting more than 15 cigarettes per day</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>